From [24,25], TRPV1 and TRPA1 have been demonstrated in neuropathic pain associated with diabetes or the administration of chemotherapeutics, probably mediated by the synthesis of reactive oxygen and nitrogen species [26,27], which are well-known TRPA1 activators [28,29]. Here, TRPA1 is linked to diabetes mellitus.